Financials
- Financial year
- 2025
- Total assets
- €378,915
- Profit
- €50,096
- Solvency
- 18.5%
Astgen Leboeuf
ActiveSummary
Astgen Leboeuf has been active since 2025 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €70,096 and a net result of €50,096. Its solvency ranks better than 37% of 22,650 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Overview
Activity
Retail sale of pharmaceutical products
NACE 47730
1 site
Size
≈ €390,000turnover 2025, estimated
- Equity
- €70,096
- Profit
- €50,096
Turnover estimated from the gross margin
Why 71raises riskFounded in 2025Sector: Retail trade (NACE 47)lowers riskLiquidity: current ratio 1.66, cash €84,588Size: total assets €378,915Show the evidence
Checked score
Score 2025
71
/ 100
Healthy
Probability in this band: 0.55% to 1.5%
Financially better than 62% of its sector peers (NACE 47, micro)
Financial strength
Strong
Solvency
43
equity 18.5% of total assets
Liquidity
66
short-term debt 29.5% · cash 22.3%
Profitability
85
return on assets 13.2%
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
About 6 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
06-2026: 1.9%
07-2026: 1.9%● unchanged vs 06-2026highest value
08-2026: 0.6%▼ -1.3 percentage points vs 07-2026lowest value
09-2026: 0.6%● unchanged vs 08-2026
10-2026: 0.6%● unchanged vs 09-2026
Credit of up to €4,500 on 30-day terms is acceptable
Liquidity ample (current ratio 1.66, above the usual 1.5; short-term debt: 29.5% and cash: 22.3% of total assets), but 81.5% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro): better than 34% on solvency, 72% on liquidity and 80% on profitability.
The bankruptcy probability was computed on 30-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskraises riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 15-07-2026, 16 days ahead of the deadline.
NBB · 1 filingDeviation from the deadline
2025
16 days early
← before the deadline
after the deadline →
Searched, nothing found (1)
- Annual accounts filedfinancial year 2025 · micro…
- MiscellaneousCapital increase · Capital contribution…
- IncorporationAppointments: ASTGEN Sacha (administrateurnonstatutaire) and…
Key points
By topic
Board & ownership
- Board
- 2 members
- Antoine LeboeufDirector
- ASTGEN SachaDirector
Network & group
- Connected companies
- 1
Timeline
- Events
- 3
- Since
- 2025
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Founded
- 07-05-2025
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Articles of association
- Provisions read
- 33
- Annual meeting
- Second Wednesday of June at 18:00
Key facts about Astgen Leboeuf
- What is the company number of Astgen Leboeuf?
- 1023.100.570. In Belgium the VAT number is the company number with BE in front: BE 1023.100.570.
- Where is Astgen Leboeuf based?
- The registered office is at Roodebeeksteenweg 241, 1200 Sint-Lambrechts-Woluwe.Company details
- What does Astgen Leboeuf do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of Astgen Leboeuf?
- Private limited company (BV).
- When was Astgen Leboeuf founded?
- On 07-05-2025.
- Is Astgen Leboeuf still active?
- Yes, Astgen Leboeuf is an active enterprise in the KBO register.
- What is the turnover of Astgen Leboeuf?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.Financials
- Is Astgen Leboeuf profitable?
- In financial year 2025, Astgen Leboeuf made a profit of €50,096.
- Where can I find the annual accounts of Astgen Leboeuf?
- Astgen Leboeuf filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Companies related to Astgen Leboeuf
Comparable companies
- Apotheek DemapharmGrimbergen
- NIEMEGEERS-ENGELS BVAsse
- PHARMACIE MOLINVAUXLiège
- APOTHEEK STENENBRUGAntwerpen
- PHARMACIE DU QUARTIER BREUGHELBrussel
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.